Publications

Found 2 results
Filters: Author is T. Gunel  [Clear All Filters]
2011
T. Gunel, Kalelioglu, I., Gedikbasi, A., Ermis, H., and Aydinli, K., Detection of fetal RHD pseudogene (RHDΨ) and hybrid RHD-CE-Ds from RHD-negative pregnant women with a free DNA fetal kit, vol. 10, pp. 2653-2657, 2011.
Bennett PR, Le Van Kim C, Colin Y, Warwick RM, et al. (1993). Prenatal determination of fetal RhD type by DNA amplification. N. Engl. J. Med. 329: 607-610. http://dx.doi.org/10.1056/NEJM199308263290903 PMid:8341334 Bombard AT, Akolekar R, Farkas DH, VanAgtmael AL, et al. (2011). Fetal RHD genotype detection from circulating cell-free fetal DNA in maternal plasma in non-sensitized RhD negative women. Prenat. Diagn. 31: 802-808. http://dx.doi.org/10.1002/pd.2770 PMid:21626507 Chen JC, Lin TM, Chen YL, Wang YH, et al. (2004). RHD 1227A is an important genetic marker for RhD(el) individuals. Am. J. Clin. Pathol. 122: 193-198. http://dx.doi.org/10.1309/3XMF2NV5707TJE7X PMid:15323135 Chinen PA, Nardozza LM, Martinhago CD, Camano L, et al. (2010). Noninvasive determination of fetal rh blood group, D antigen status by cell-free DNA analysis in maternal plasma: experience in a Brazilian population. Am. J. Perinatol. 27: 759-762. http://dx.doi.org/10.1055/s-0030-1253560 PMid:20408112 Daniels G, van der Schoot CE and Olsson ML (2007). Report of the second international workshop on molecular blood group genotyping. Vox Sang. 93: 83-88. http://dx.doi.org/10.1111/j.1423-0410.2007.00926.x PMid:17547570 Daniels G, Finning K, Martin P and Massey E (2009). Noninvasive prenatal diagnosis of fetal blood group phenotypes: current practice and future prospects. Prenat. Diagn. 29: 101-107. http://dx.doi.org/10.1002/pd.2172 PMid:19085963 Faas BHW, Beckers EAM, Wildoer P, Lightart PC, et al. (1997). Molecular background of VS and weak C expression in blacks. Transfusion 37: 38-44. http://dx.doi.org/10.1046/j.1537-2995.1997.37197176949.x PMid:9024488 Huang CH (1998). The human Rh50 glycoprotein gene. Structural organization and associated splicing defect resulting in Rh(null) disease. J. Biol. Chem. 273: 2207-2213. http://dx.doi.org/10.1074/jbc.273.4.2207 PMid:9442063 Rodrigues A, Rios M, Pellegrino J Jr, Costa FF, et al. (2002). Presence of the RHD pseudogene and the hybrid RHD-CE-D(s) gene in Brazilians with the D-negative phenotype. Braz. J. Med. Biol. Res. 35: 767-773. http://dx.doi.org/10.1590/S0100-879X2002000700002 PMid:12131915 Rouillac-Le SC, Puillandre P, Gillot R, Baulard C, et al. (2004). Large-scale pre-diagnosis study of fetal RHD genotyping by PCR on plasma DNA from RhD-negative pregnant women. Mol. Diagn. 8: 23-31. http://dx.doi.org/10.2165/00066982-200408010-00004 PMid:15230639 Rouillac-Le SC, Serazin V, Brossard Y, Oudin O, et al. (2007). Noninvasive fetal RHD genotyping from maternal plasma. Use of a new developed Free DNA Fetal Kit RhD. Transfus. Clin. Biol. 14: 572-577. http://dx.doi.org/10.1016/j.tracli.2008.01.003 PMid:18375165 Scheffer P, van der Schoot C, Page-Christiaens G and de Haas M (2011). Noninvasive fetal blood group genotyping of rhesus D, c, E and of K in alloimmunised pregnant women: evaluation of a 7-year clinical experience. BJOG 118: 1340-1348. http://dx.doi.org/10.1111/j.1471-0528.2011.03028.x Singleton BK, Green CA, Avent ND, Martin PG, et al. (2000). The presence of an RHD pseudogene containing a 37 base pair duplication and a nonsense mutation in africans with the Rh D-negative blood group phenotype. Blood 95: 12-18. PMid:10607679 Wagner FF and Flegel WA (2000). RHD gene deletion occurred in the Rhesus box. Blood 95: 3662-3668. PMid:10845894
T. Gunel, Zeybek, Y. G., Akçakaya, P., Kalelioglu, I., Benian, A., Ermis, H., and Aydinli, K., Serum microRNA expression in pregnancies with preeclampsia, vol. 10, pp. 4034-4040, 2011.
Baehrecke EH (2003). miRNAs: micro managers of programmed cell death. Curr. Biol. 13: R473-R475. http://dx.doi.org/10.1016/S0960-9822(03)00405-6 Calin GA, Ferracin M, Cimmino A, Di Leva G, et al. (2005). A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N. Engl. J. Med. 353: 1793-1801. http://dx.doi.org/10.1056/NEJMoa050995 PMid:16251535 Carty DM, Delles C and Dominiczak AF (2008). Novel biomarkers for predicting preeclampsia. Trends Cardiovasc. Med. 18: 186-194. http://dx.doi.org/10.1016/j.tcm.2008.07.002 PMid:18790389 PMCid:2577131 Chien PF, Arnott N, Gordon A, Owen P, et al. (2000). How useful is uterine artery Doppler flow velocimetry in the prediction of pre-eclampsia, intrauterine growth retardation and perinatal death? An overview. BJOG 107: 196-208. http://dx.doi.org/10.1111/j.1471-0528.2000.tb11690.x PMid:10688503 Chim SS, Shing TK, Hung EC, Leung TY, et al. (2008). Detection and characterization of placental microRNAs in maternal plasma. Clin. Chem. 54: 482-490. http://dx.doi.org/10.1373/clinchem.2007.097972 PMid:18218722 Esau C, Kang X, Peralta E, Hanson E, et al. (2004). MicroRNA-143 regulates adipocyte differentiation. J. Biol. Chem. 279: 52361-52365. http://dx.doi.org/10.1074/jbc.C400438200 PMid:15504739 Gilad S, Meiri E, Yogev Y, Benjamin S, et al. (2008). Serum microRNAs are promising novel biomarkers. PLoS One 3: e3148. http://dx.doi.org/10.1371/journal.pone.0003148 PMid:18773077 PMCid:2519789 Hahn S, Gupta AK, Troeger C, Rusterholz C, et al. (2006). Disturbances in placental immunology: ready for therapeutic interventions? Springer Semin. Immunopathol. 27: 477-493. http://dx.doi.org/10.1007/s00281-006-0016-5 PMid:16738957 Krichevsky AM, King KS, Donahue CP, Khrapko K, et al. (2003). A microRNA array reveals extensive regulation of microRNAs during brain development. RNA 9: 1274-1281. http://dx.doi.org/10.1261/rna.5980303 PMid:13130141 PMCid:1370491 Lagos-Quintana M, Rauhut R, Lendeckel W and Tuschl T (2001). Identification of novel genes coding for small expressed RNAs. Science 294: 853-858. http://dx.doi.org/10.1126/science.1064921 PMid:11679670 Lai EC (2002). Micro RNAs are complementary to 3' UTR sequence motifs that mediate negative post-transcriptional regulation. Nat. Genet. 30: 363-364. http://dx.doi.org/10.1038/ng865 PMid:11896390 Lee RC and Ambros V (2001). An extensive class of small RNAs in Caenorhabditis elegans. Science 294: 862-864. http://dx.doi.org/10.1126/science.1065329 PMid:11679672 Lo YM, Corbetta N, Chamberlain PF, Rai V, et al. (1997). Presence of fetal DNA in maternal plasma and serum. Lancet 350: 485-487. http://dx.doi.org/10.1016/S0140-6736(97)02174-0 Michael MZ, O'Connor SM, van Holst Pellekaan NG, Young GP, et al. (2003). Reduced accumulation of specific microRNAs in colorectal neoplasia. Mol. Cancer Res. 1: 882-891. PMid:14573789 Mütze S, Rudnik-Schoneborn S, Zerres K and Rath W (2008). Genes and the preeclampsia syndrome. J. Perinat. Med. 36: 38-58. http://dx.doi.org/10.1515/JPM.2008.004 PMid:18184097 Ng EK, Tsui NB, Lau TK, Leung TN, et al. (2003). mRNA of placental origin is readily detectable in maternal plasma. Proc. Natl. Acad. Sci. U. S. A. 100: 4748-4753. http://dx.doi.org/10.1073/pnas.0637450100 PMid:12644709 PMCid:153627 Pineles BL, Romero R, Montenegro D, Tarca AL, et al. (2007). Distinct subsets of microRNAs are expressed differentially in the human placentas of patients with preeclampsia. Am. J. Obstet. Gynecol. 196: 261-266. http://dx.doi.org/10.1016/j.ajog.2007.01.008 PMid:17346547 Prieto DM and Markert UR (2011). MicroRNAs in pregnancy. J. Reprod. Immunol. 88: 106-111. http://dx.doi.org/10.1016/j.jri.2011.01.004 PMid:21353310 Qiu C, Luthy DA, Zhang C, Walsh SW, et al. (2004). A prospective study of maternal serum C-reactive protein concentrations and risk of preeclampsia. Am. J. Hypertens 17: 154-160. http://dx.doi.org/10.1016/j.amjhyper.2003.09.011 PMid:14751658 Redman CW and Sargent IL (2005). Latest advances in understanding preeclampsia. Science 308: 1592-1594. http://dx.doi.org/10.1126/science.1111726 PMid:15947178 Smets EM, Visser A, Go AT, van Vugt JM, et al. (2006). Novel biomarkers in preeclampsia. Clin. Chim. Acta 364: 22-32. http://dx.doi.org/10.1016/j.cca.2005.06.011 PMid:16139262 Tjoa ML, van Vugt JM, Go AT, Blankenstein MA, et al. (2003). Elevated C-reactive protein levels during first trimester of pregnancy are indicative of preeclampsia and intrauterine growth restriction. J. Reprod. Immunol. 59: 29-37. http://dx.doi.org/10.1016/S0165-0378(02)00085-2 Tsui NB, Chim SS, Chiu RW, Lau TK, et al. (2004). Systematic micro-array based identification of placental mRNA in maternal plasma: towards non-invasive prenatal gene expression profiling. J. Med. Genet. 41: 461-467. http://dx.doi.org/10.1136/jmg.2003.016881 PMid:15173234 PMCid:1735812 WHO (2005). The World Health Report: Make Every Mother and Child Safe. World Health Organization, Geneva.